Country: United States
Language: English
Source: NLM (National Library of Medicine)
NITROFURANTOIN (UNII: 927AH8112L) (NITROFURANTOIN - UNII:927AH8112L)
Mylan Pharmaceuticals Inc.
NITROFURANTOIN
NITROFURANTOIN 50 mg
ORAL
PRESCRIPTION DRUG
Nitrofurantoin macrocrystals capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin macrocrystals capsules and other antibacterial drugs, nitrofurantoin macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other therapeut
Nitrofurantoin Capsules, USP (Macrocrystals) are available containing 50 mg or 100 mg of nitrofurantoin (macrocrystals), USP. The 50 mg capsules are hard-shell gelatin capsules with a light brown opaque cap and light brown opaque body filled with a yellow powder. The capsules are axially printed with MYLAN over 1650 in black ink on both the cap and the body. They are available as follows: NDC 0378-1650-01 bottles of 100 capsules NDC 0378-1650-05 bottles of 500 capsules The 100 mg capsules are hard-shell gelatin capsules with a gray opaque cap and gray opaque body filled with a yellow powder. The capsules are axially printed with MYLAN over 1700 in black ink on both the cap and the body. They are available as follows: NDC 0378-1700-01 bottles of 100 capsules NDC 0378-1700-05 bottles of 500 capsules Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. To report SUSPECTED ADVERSE REACTIONS, contact Mylan at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. The brands listed are registered trademarks of their respective owners. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 7/2018 NTFT:R6
Abbreviated New Drug Application
NITROFURANTOIN (MACROCRYSTALS)- NITROFURANTOIN (MACROCRYSTALS) CAPSULE MYLAN PHARMACEUTICALS INC. ---------- To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin macrocrystals capsules and other antibacterial drugs, nitrofurantoin macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Nitrofurantoin macrocrystals is a synthetic chemical of controlled crystal size. It is a stable, brown yellow macrocrystalline powder. Nitrofurantoin macrocrystals is an antibacterial agent for specific urinary tract infections. It is available in 50 mg and 100 mg capsules for oral administration. Nitrofurantoin macrocrystals capsules has the following structural formula: 1-[(5-Nitrofurfurylidene)amino]hydantoin Each capsule contains the following inactive ingredients: corn starch and lactose monohydrate. The 50 mg capsules also contain colloidal silicon dioxide, magnesium stearate and sodium lauryl sulfate and the 100 mg capsules also contain talc. Each empty hard shell gelatin capsule also contains gelatin, sodium lauryl sulfate, titanium dioxide and yellow iron oxide. The 50 mg empty hard shell gelatin capsules also contain red iron oxide and the 100 mg capsules also contain black iron oxide. In addition, the black imprinting ink contains black iron oxide, D&C Yellow No. 10 Aluminum Lake, FD&C Blue No. 1 Aluminum Lake, FD&C Blue No. 2 Aluminum Lake, FD&C Red No. 40 Aluminum Lake, propylene glycol and shellac glaze. CLINICAL PHARMACOLOGY Nitrofurantoin macrocrystals is a larger crystal form of Furadantin (nitrofurantoin). The absorption of nitrofurantoin macrocrystals capsules is slower and its excretion somewhat less when compared to Furadantin. Blood concentrations at therapeutic dosage are usually low. It is highly soluble in urine, to which it may impart a brown color. Following a dose regimen of 100 mg q.i.d. for 7 days, average urinary drug recoveries (0-24 hours) on day 1 and day 7 Read the complete document